Cadila Healthcare board to consider Unaudited financial results

06 Oct 2015 Evaluate

Cadila Healthcare has informed that a Meeting of the Board of Directors of the Company will be held on October 22, 2015, to consider & approve the unaudited financial results for the quarter and half year ended on September 30, 2015 (Q2). Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed from October 12, 2015 to October 26, 2015 for all Directors and designated officers of the Company.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×